Compare UONEK & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UONEK | CCEL |
|---|---|---|
| Founded | 1980 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Managed Health Care |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.9M | 32.7M |
| IPO Year | N/A | 1997 |
| Metric | UONEK | CCEL |
|---|---|---|
| Price | $7.90 | $3.41 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.2K | ★ 16.6K |
| Earning Date | 11-04-2025 | 02-27-2026 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $393,670,000.00 | $31,747,500.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.40 | $3.10 |
| 52 Week High | $14.00 | $8.79 |
| Indicator | UONEK | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 90.04 | 40.29 |
| Support Level | $7.60 | $3.37 |
| Resistance Level | $8.83 | $3.53 |
| Average True Range (ATR) | 0.31 | 0.16 |
| MACD | 0.93 | 0.02 |
| Stochastic Oscillator | 92.14 | 42.11 |
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.